Business ❯Economics ❯Market Trends
Investments Market Trends Electric Vehicles Electric Vehicles Investment Innovation Clinical Trials Corporate Strategy FDA Investing
Despite a 52% rebound in Tesla shares, Gerber remains skeptical about the company's fundamentals, citing technology, sales, and leadership challenges ahead of the anticipated robotaxi launch.